◆BLACKSPECTER AI Chat öffnen →

BlackSpecter›Aktien›BEAM

BEAM (BEAM)

Kennzahlen

Marktkapitalisierung

n/a

KGV (TTM)

n/a

Umsatz (TTM)

n/a

EBITDA

n/a

Dividendenrendite

n/a

52W Hoch

n/a

52W Tief

n/a

Beta

n/a

EPS (TTM)

n/a

Forward KGV

n/a

PEG Ratio

n/a

Short-Quote

n/a

Analysten-Ratings

Keine Analysten-Daten verfügbar

Earnings

Keine Earnings-Daten verfügbar

Aktuelle News

Simply Wall St.·vor 4 Tagen

Beam Therapeutics (BEAM) Stock May Look Stretched As Sales Expectations Climb

Zacks·vor 5 Tagen

4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains

GlobeNewswire·vor 23 Tagen

Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Zacks·vor 24 Tagen

BEAM's Q2 Loss Wider Than Expected, Revenues Fall Y/Y, Pipeline in Focus

MT Newswires·vor 24 Tagen

BofA Adjusts Price Target on Beam Therapeutics to $43 From $47

Zacks·vor 25 Tagen

Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Lags Revenue Estimates

Frag BlackSpecter AI über BEAM

Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.

Ist BEAM kaufenswert?BEAM Earnings Analyse BEAM Bewertung

AI Chat öffnen →